The intrinsic “on-target” effect of IDO1 catalytic inhibitors in FTC-133 cells is mediated by the stabilization of the IDO1 protein in a non-enzymatic conformation suitable for mediating signal transduction in the tumor cells that results in an adverse effect. The gene discussed is IDO1; the disease is neoplasm.